Journal of Viral Hepatitis (via Wiley Online Library), London, 2021. 11p.
Data were extracted from 11 services that specialize in the care of people who inject drugs. The cumulative number of testing opportunities missed during lockdowns may prolong efforts to find the remaining population of PWID living with undiagnosed hep C.
Communicable Diseases Intelligence, Canberra, 2024. 27p.
Found that there was an overall reduction in most of Australia’s nationally notifiable diseases over the 2 pandemic years during which wide-scale public health measures remained in operation, particularly for 23 social and imported diseases.
National Drug & Alcohol Research Centre (NDARC), Sydney, 2024. 106p. report;
Increases understanding of older adults who experience the greatest harm from alcohol and other drug (AOD) consumption and identifies high-risk groups and risk factors.
Sydney Children’s Hospital Network, Sydney, 2024. 4p. or audio file.
Especially relevant for children and teenagers: methods of transmission, symptoms, methods of diagnosis, treatment, management, prevention, and travel issues.
BMC Pubic Health (via Springer Nature), London, 2024. 19p.
Alcohol and drug use remained important risk factors for disability-adjusted life years among people aged 15–19 years.
Burnet Inst & Kirby Inst, Melbourne, 2024. 83p.
Rates of new hep C infections steadily declining: reductions among people attending primary care and a sample who inject drugs, increased testing in some settings but still areas for improvement.
WHA, Geneva, 2024. 1p.
Testing, treatment and follow up info for mothers, babies, partners and families. Scroll down page for versions for mothers-to-be and healthcare workers.
Hepatitis SA, Adelaide, 2024. 3 fold brochure.
Describes Hep SA's Peer based Needle and Syringe Program, including what equipment the service provides, what sessional peers do (and where to find them) – and its importance as a health issue.
Medical News Today, Bexhill-on-Sea, 2024. 4p.
Learn more about how HBV (and other forms of hepatitis) is transmitted between people – and how individuals can protect themselves.
Harm Reduction International, London, 2024. 211p.
The report includes 9 regional chapters authored by experts from each region. This year’s report emphasises key regional issues and populations that continue to be neglected by harm reduction services.
Journal of Viral Hepatitis (via (Wiley Online), London, 2024. 11p. (pre-publication view).
Outreach models of care incur large upfront costs but can capture unreached populations and result in comparable or favourable cost per cure, due to higher levels of engagement and lower rates of loss to follow-up.
Nature: Scientific Reports, London, 2024. 8p.
Achieving sustained virological response was associated with a significantly reduced risk of HCC. These findings highlight the importance of early DAA treatment, particularly for patients with cirrhosis.
Medical News Today, Bexhill-on-Sea, 2024. 8p.
How does living with chronic pain feel? And how do the body and brain deal with it? This article explains what may cause chronic pain, its affects - and some management techniques.
Hepatitis SA, Adelaide, 2024. 1p. factsheet.
Fact sheet with key information on living well with hepatitis B. In Vietnamese. For print version email communications@hepsa.asn.au.
LiverWELL, Melbourne, 2009. 2p.
Lists common painkillers (Paracetamol, Iboprufin, Aspirin and Codeine) what they are used for and what effect they can have on the liver – especially for those with liver disease.
John Hopkins Medicine, Baltimore, (undated). 4p.
Debunks 5 myths about liver cleansing, including : after indulging, as a way to lose weight, as a protection against liver disease, as a way to correct liver damage, and whether obesity increases liver damage risk.
National Aboriginal Community Controlled Health Organisation (NACCHO), Canberra, 2021. 5p.
For patients and health workers: can be set up with info about the medicine, how and when to take and what it does. With text or images.
BMC Public Health (Via Springer Nature), London, 2024. 9p.
In recent years, HCV rates among women have increased, resulting in an urgent need to address stigma and its harmful effects. This analysis investigates stigma in the context of women living with HCV using Rodgers’ evolutionary method.
Harm Reduction Journal (via BioMed Central), London, 2024. 10p.
Current levels of risky behaviour have reportedly been reduced by PWID over the past few years, but educational and motivational interventions to increase hep C treatment uptake should address gaps in patients’ knowledge.
International Journal of Drug Policy (via Elsevier), London, 2024. 10p.
Evidence showing substantial reductions in HCV associated with increase of HCV treatment scale-up in the community thus supporting the effectiveness of HCV treatment as prevention in people who inject drugs.
Aust. Dept. of Health and Aged Care, Canberra, 2024. Video 6 minutes.
Deadly comedian Janty Blair yarns with Aboriginal Health Practitioner, Jecinta from Darwin. In ‘True or Gammon’ style, they shed light on STI myths.
Clinical Care Options, Reston VA, 2023. Training video series.
Patients and faculty discuss barriers and solutions for HBV care for older adults with CHB, including awareness, updated screening and vaccination, understanding late HBV diagnosis and/or treatment.
WA Department of Health, Perth, 2024. 47p.
Roadmap to prevention and control of STIs and BBVs and aims to minimise the impact of stigma and discrimination experienced by affected populations (strategy and action plans available).
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.